Within-host adaptation mutations associated with persistent colonization of Pseudomonas aeruginosa in a silicosis

Furong Zhang1, Lvxin Qian2, Yi Yan2

  • 1Department of Clinical Laboratory, Pengzhou People's Hospital, Chengdu, Sichuan, China.

Insights

Two Pseudomonas aeruginosa strains from a silicosis patient, identified as the high-risk ST274 clone, exhibit imipenem resistance and mucoid characteristics due to specific gene mutations. These strains show altered growth, virulence, and stress resistance, offering insights into chronic infection adaptation.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections in immunocompromised individuals.
  • Silicosis patients are susceptible to chronic bacterial infections.

Purpose of the Study:

  • To characterize two mucoid, imipenem-resistant P. aeruginosa strains (SCPa14 and SCPa16) isolated from a silicosis patient.
  • To investigate the genetic basis and adaptive strategies of these strains during chronic infection.

Main Methods:

  • Whole-genome sequencing
  • Gene sequence analysis
  • Phenotypic characterization (growth, motility, pyocyanin production, H2O2 resistance, biofilm formation, iron restriction, antimicrobial peptide/serum resistance)
  • Galleria mellonella infection model

Main Results:

  • Both strains belong to the ST274 clone and possess mutations in mucA and oprD genes, conferring mucoid phenotype and imipenem resistance.
  • Strains exhibit altered phenotypes including slow growth, reduced motility, increased pyocyanin, enhanced H2O2 resistance, and differential biofilm formation.
  • Impaired iron acquisition and resistance to LL-37/serum complement, alongside low virulence in G. mellonella, were observed.

Conclusions:

  • The study elucidates adaptive mechanisms and fitness costs of P. aeruginosa in a silicosis patient's chronic infection.
  • Identified mutations and phenotypic traits provide insights into strain evolution and potential therapeutic targets.